Uncategorized
Ocular Therapeutix™ to Participate in Two Investor Conferences in September 2015
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences in September including: Citi 10th Annual Biotech ConferencePanel: Envisioning the Future of Novel Ophthalmic Therapies and Drug Delivery StrategiesWed
